Search Result

Results for "

CEND-1-13C6,15N2

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Complement System (2) Integrin (2) Isotope-Labeled Compounds (2)
By Research Areas:	Cancer (2)

Inhibitors & Agonists

Peptides

Isotope-Labeled Compounds

Targets Recommended: P-glycoprotein

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P3448S1

Certepetide-13C2,15N CEND-1-<sup>13sup>C<sub>2sub>,<sup>15sup>N; iRGD-<sup>13sup>C<sub>2sub>,<sup>15sup>N; LSTA1-<sup>13sup>C<sub>2sub>,<sup>15sup>N	Isotope-Labeled Compounds Complement System Integrin	Cancer
Certepetide- ¹³C₂, ¹⁵N (CEND-1- ¹³C₂, ¹⁵N) is the ¹³C- and ¹⁵N-labeled Certepetide (HY-P3448). Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary agent conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors .

HY-P3448S

Certepetide-13C6,15N2 CEND-1-<sup>13sup>C<sub>6sub>,<sup>15sup>N<sub>2sub>; iRGD-<sup>13sup>C<sub>6sub>,<sup>15sup>N<sub>2sub>; LSTA1-<sup>13sup>C<sub>6sub>,<sup>15sup>N<sub>2sub>	Isotope-Labeled Compounds Complement System Integrin	Cancer
Certepetide- ¹³C₆, ¹⁵N₂ (CEND-1- ¹³C₆, ¹⁵N₂) is the ¹³C- and ¹⁵N-labeled Certepetide (HY-P3448). Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary agent conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors .

Cat. No.	Product Name	Target	Research Area

HY-P3448S1

Certepetide-13C2,15N CEND-1-<sup>13sup>C<sub>2sub>,<sup>15sup>N; iRGD-<sup>13sup>C<sub>2sub>,<sup>15sup>N; LSTA1-<sup>13sup>C<sub>2sub>,<sup>15sup>N	Isotope-Labeled Compounds Complement System Integrin	Cancer
Certepetide- ¹³C₂, ¹⁵N (CEND-1- ¹³C₂, ¹⁵N) is the ¹³C- and ¹⁵N-labeled Certepetide (HY-P3448). Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary agent conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors .

HY-P3448S

Certepetide-13C6,15N2 CEND-1-<sup>13sup>C<sub>6sub>,<sup>15sup>N<sub>2sub>; iRGD-<sup>13sup>C<sub>6sub>,<sup>15sup>N<sub>2sub>; LSTA1-<sup>13sup>C<sub>6sub>,<sup>15sup>N<sub>2sub>	Isotope-Labeled Compounds Complement System Integrin	Cancer
Certepetide- ¹³C₆, ¹⁵N₂ (CEND-1- ¹³C₆, ¹⁵N₂) is the ¹³C- and ¹⁵N-labeled Certepetide (HY-P3448). Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary agent conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors .

Cat. No.	Product Name	Chemical Structure

HY-P3448S1

Certepetide-13C2,15N
Certepetide- ¹³C₂, ¹⁵N (CEND-1- ¹³C₂, ¹⁵N) is the ¹³C- and ¹⁵N-labeled Certepetide (HY-P3448). Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary agent conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors .

Certepetide-13C2,15N

Certepetide- ¹³C₂, ¹⁵N (CEND-1- ¹³C₂, ¹⁵N) is the ¹³C- and ¹⁵N-labeled Certepetide (HY-P3448). Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary agent conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors .

HY-P3448S

Certepetide-13C6,15N2
Certepetide- ¹³C₆, ¹⁵N₂ (CEND-1- ¹³C₆, ¹⁵N₂) is the ¹³C- and ¹⁵N-labeled Certepetide (HY-P3448). Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary agent conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors .

Certepetide-13C6,15N2

Certepetide- ¹³C₆, ¹⁵N₂ (CEND-1- ¹³C₆, ¹⁵N₂) is the ¹³C- and ¹⁵N-labeled Certepetide (HY-P3448). Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary agent conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Name
Email *

	Sorry, but the email address you supplied was invalid.

CEND-1-<sup>13</sup>C<sub>6</sub>,<sup>15</sup>N<sub>2</sub>

Inhibitors & Agonists

Peptides

Isotope-Labeled Compounds